MISTIE COLLINS: Open Payments
NPI 1104128651 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 47 payments from 10 companies in 2025. Trend: 2023 $84 · 2024 $457 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $344 |
| ABBVIE INC. | 19 | $223 |
| Indivior Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Edwards Lifesciences Corporation | 1 | $42 |
| Alkermes, Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Braeburn Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
Products named: Auvelity, VRAYLAR, SUBLOCADE, REXULTI, SAPIEN 3 Ultra RESILIA, VIVITROL, CAPLYTA, APTIMA.
Industry payments across KY — which companies pay providers there.
